Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Aug-18 5:00 PM View:  | Spigelman Melvin K Director | Synergy Pharmaceuticals, Inc. (SGYP) | 15-Aug-18 | Payment of Exercise | 101,695 | -- | -- | (68%) 150.0K to 48.3K | |
| 16-Aug-18 5:00 PM View: | Spigelman Melvin K Director | Synergy Pharmaceuticals, Inc. (SGYP) | 15-Aug-18 | Option Exercise | 150,000 | $1.20 | $180,000.00 | 100% 0 to 150.0K | |
| 06-Jul-18 4:31 PM View: | Brancaccio John P Director | Synergy Pharmaceuticals, Inc. (SGYP) | 04-Jul-18 | Payment of Exercise | 13,896 | -- | -- | (11%) 130.47K to 116.57K | |
| 06-Jul-18 4:31 PM View: | Brancaccio John P Director | Synergy Pharmaceuticals, Inc. (SGYP) | 04-Jul-18 | Option Exercise | 50,023 | $0.50 | $25,011.50 | 62% 80.44K to 130.47K | |
| 06-Jul-18 4:31 PM View: | Adams Thomas Phd Director | Synergy Pharmaceuticals, Inc. (SGYP) | 03-Jul-18 | Payment of Exercise | 27,785 | -- | -- | (28%) 100.02K to 72.24K | |
| 06-Jul-18 4:31 PM View: | Adams Thomas Phd Director | Synergy Pharmaceuticals, Inc. (SGYP) | 03-Jul-18 | Option Exercise | 100,023 | $0.50 | $50,011.50 | 100% 0 to 100.02K | |
| 18-Jun-18 4:30 PM View: | Jacob Gary S Executive Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 15-Jun-18 | Option Exercise | 474,961 | $0.50 | $237,480.00 | 118% 402.68K to 877.64K | |
| 18-Jun-18 4:30 PM View: | Jacob Gary S Executive Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 15-Jun-18 | Payment of Exercise | 282,180 | -- | -- | (32%) 877.64K to 595.46K | |
| 02-Apr-18 5:00 PM View: | Brancaccio John P Director | Synergy Pharmaceuticals, Inc. (SGYP) | 02-Apr-18 | Option Exercise | 50,000 | $0.50 | $25,000.00 | 186% 26.94K to 76.94K | |
| 14-Nov-17 4:36 PM View: | Paulson & Co Inc 10% Owner | Synergy Pharmaceuticals, Inc. (SGYP) | 10-Nov-17 | Market Sale | 8,750,000 | $2.82 | $24,678,500.00 | (36%) 24.06M to 15.31M | 90% |
| 09-Aug-17 6:17 PM View: | Paulson & Co Inc 10% Owner | Synergy Pharmaceuticals, Inc. (SGYP) | 07-Aug-17 | Market Sale | 26,287 | $3.77 | $98,971.90 | (< 1%) 24.09M to 24.06M | 92% |
| 30-May-17 7:55 AM View: | Jacob Gary S Chief Executive Officer Director | Synergy Pharmaceuticals, Inc. (SGYP) | 26-May-17 | Market Purchase | 5,680 | $3.52 | $19,967.50 | 1% 397.0K to 402.68K | (92%) |
| 30-May-17 7:56 AM View: | Brancaccio John P Director | Synergy Pharmaceuticals, Inc. (SGYP) | 26-May-17 | Market Purchase | 6,500 | $3.59 | $23,335.00 | 27% 23.94K to 30.44K | (92%) |
| 08-Nov-16 4:44 PM View: | Paulson & Co Inc 10% Owner | Synergy Pharmaceuticals, Inc. (SGYP) | 04-Nov-16 | Market Sale | 140,000 | $4.24 | $593,936.00 | (< 1%) 24.23M to 24.09M | 93% |
| 29-Sep-16 5:22 PM View: | Paulson & Co Inc 10% Owner | Synergy Pharmaceuticals, Inc. (SGYP) | 28-Sep-16 | Market Sale | 20,700 | $5.60 | $116,005.00 | (< 1%) 24.25M to 24.23M | 95% |
| 29-Sep-16 5:22 PM View: | Paulson & Co Inc 10% Owner | Synergy Pharmaceuticals, Inc. (SGYP) | 27-Sep-16 | Market Sale | 33,600 | $5.75 | $193,059.00 | (< 1%) 24.28M to 24.25M | 95% |
| 21-Sep-16 4:31 PM View: | Brancaccio John P Director | Synergy Pharmaceuticals, Inc. (SGYP) | 19-Sep-16 | Market Option Sale | 2,518 | $5.76 | $14,503.70 | (11%) 22.96K to 20.44K | 95% |
| 21-Sep-16 4:31 PM View: | Brancaccio John P Director | Synergy Pharmaceuticals, Inc. (SGYP) | 19-Sep-16 | Option Exercise | 2,518 | $4.47 | $11,251.90 | 12% 20.44K to 22.96K | |
| 20-Sep-16 6:12 PM View: | Paulson & Co Inc 10% Owner | Synergy Pharmaceuticals, Inc. (SGYP) | 19-Sep-16 | Market Sale | 1,500,000 | $5.61 | $8,415,000.00 | (6%) 25.78M to 24.28M | 95% |
| 20-Sep-16 6:12 PM View: | Paulson & Co Inc 10% Owner | Synergy Pharmaceuticals, Inc. (SGYP) | 16-Sep-16 | Market Sale | 1,973,710 | $5.61 | $11,075,100.00 | (7%) 27.76M to 25.78M | 95% |
| 16-Sep-15 4:15 PM View: | Denoyer Bernard Senior Vice President, Finance | Synergy Pharmaceuticals, Inc. (SGYP) | 14-Sep-15 | Market Option Sale | 10,000 | $7.50 | $75,000.00 | (100%) 10.0K to 0 | 96% |
| 16-Sep-15 4:15 PM View: | Denoyer Bernard Senior Vice President, Finance | Synergy Pharmaceuticals, Inc. (SGYP) | 14-Sep-15 | Option Exercise | 10,000 | $3.40 | $34,000.00 | 100% 0 to 10.0K | |
| 14-Sep-15 4:16 PM View: | Joslyn Alan Director | Synergy Pharmaceuticals, Inc. (SGYP) | 11-Sep-15 | Option Exercise | 13,754 | $3.95 | $54,328.30 | 100% 0 to 13.75K | |
| 14-Sep-15 4:16 PM View: | Joslyn Alan Director | Synergy Pharmaceuticals, Inc. (SGYP) | 11-Sep-15 | Market Option Sale | 13,754 | $7.22 | $99,346.90 | (100%) 13.75K to 0 | 96% |
| 01-Jul-15 5:01 PM View: | Jacob Gary S Chief Executive Officer Director | Synergy Pharmaceuticals, Inc. (SGYP) | 01-Jul-15 | Option Exercise | 62,965 | $5.61 | $353,234.00 | 19% 334.03K to 397.0K | |
| 03-Jun-14 1:46 PM View: | Brancaccio John P Director | Synergy Pharmaceuticals, Inc. (SGYP) | 03-Jun-14 | Market Purchase | 3,500 | $4.12 | $14,420.00 | 17% 20.44K to 23.94K | (93%) |
| 28-May-14 10:07 AM View: | Jacob Gary S Chief Executive Officer Director | Synergy Pharmaceuticals, Inc. (SGYP) | 27-May-14 | Market Purchase | 4,000 | $4.18 | $16,720.00 | 1% 334.03K to 338.03K | (93%) |
| 28-May-14 9:17 AM View: | Denoyer Bernard Senior Vice President, Finance | Synergy Pharmaceuticals, Inc. (SGYP) | 23-May-14 | Market Purchase | 2,500 | $3.89 | $9,725.00 | 24% 10.45K to 12.95K | (93%) |
| 28-May-14 9:17 AM View: | Shailubhai Kunwar Chief Scientific Officer | Synergy Pharmaceuticals, Inc. (SGYP) | 23-May-14 | Market Purchase | 3,000 | $3.89 | $11,670.00 | 3% 88.02K to 91.02K | (93%) |
| 29-Oct-13 11:35 AM View: | Cerrone Gabriel | Synergy Pharmaceuticals, Inc. (SGYP) | 29-Oct-13 | Market Purchase | 12,000 | $4.09 | $49,080.00 | 1% 1.09M to 1.11M | (93%) |
| 24-Jun-13 7:08 AM View: | Denoyer Bernard Senior Vice President, Finance | Synergy Pharmaceuticals, Inc. (SGYP) | 21-Jun-13 | Market Purchase | 7,500 | $4.78 | $35,850.00 | 100% 0 to 7.5K | (94%) |
| 14-Jun-13 12:07 PM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 14-Jun-13 | Market Purchase | 8,000 | $4.42 | $35,360.00 | < 1% 1.09M to 1.09M | (93%) |
| 24-Apr-13 10:51 AM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 24-Apr-13 | Market Purchase | 12,500 | $4.46 | $55,750.00 | 1% 1.07M to 1.08M | (94%) |
| 24-Apr-13 12:41 PM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 24-Apr-13 | Market Purchase | 5,500 | $4.66 | $25,612.40 | 3% 182.87K to 188.37K | (94%) |
| 05-Feb-13 10:46 AM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 05-Feb-13 | Market Purchase | 4,000 | $6.18 | $24,710.80 | < 1% 1.06M to 1.07M | (95%) |
| 04-Feb-13 12:50 PM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 04-Feb-13 | Market Purchase | 13,090 | $6.04 | $79,034.80 | 1% 1.05M to 1.06M | (95%) |
| 05-Feb-13 10:46 AM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 04-Feb-13 | Market Purchase | 1,000 | $6.04 | $6,040.00 | < 1% 1.06M to 1.06M | (95%) |
| 30-Jan-13 11:39 AM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 30-Jan-13 | Grant | 26,000 | $5.98 | $155,544.00 | 3% 1.02M to 1.05M | (95%) |
| 22-Jan-13 5:27 PM View: | Hunter Robert Merrill 10% Owner | Synergy Pharmaceuticals, Inc. (SGYP) | 17-Jan-13 | Grant | 3,938,360 | -- | -- | 119% 3.31M to 7.24M | |
| 22-Jan-13 5:24 PM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 17-Jan-13 | Grant | 393,023 | -- | -- | 62% 631.23K to 1.02M | |
| 22-Jan-13 5:25 PM View: | Brancaccio John P Director | Synergy Pharmaceuticals, Inc. (SGYP) | 17-Jan-13 | Grant | 20,444 | -- | -- | 100% 0 to 20.44K | |
| 22-Jan-13 5:24 PM View: | Jacob Gary S Chief Executive Officer Director | Synergy Pharmaceuticals, Inc. (SGYP) | 17-Jan-13 | Grant | 26,490 | -- | -- | (8%) 341.28K to 314.79K | |
| 15-Nov-12 10:22 AM View: | Cerrone Gabriel Chairman Director | Synergy Pharmaceuticals, Inc. (SGYP) | 14-Nov-12 | Market Purchase | 87,820 | $3.61 | $317,250.00 | 16% 543.41K to 631.23K | (92%) |
| 15-Nov-11 6:00 AM View: | Cerrone Gabriel Director | Synergy Pharmaceuticals, Inc. (SGYP) | 14-Nov-11 | Purchase | 470,588 | $2.12 | $1,000,000.00 | 126% 374.94K to 845.53K |
